Bipolar Disorder Trial, Recruiting NCT03886584 Sponsor: Hôpital le Vinatier Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT03886584
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have freely agreed to take part and given your informed consent
  • You are a man or a woman aged between 18 and 80 years old
  • You have normal vision, or vision that is corrected with glasses or contact lenses
  • You can read and speak French
  • You do not have severe memory problems that would prevent you from completing the tests (your memory will be checked using a short questionnaire)
  • You have been diagnosed with one of the following conditions using recognised medical guidelines: a memory disorder (AM), a pre-dementia stage of Alzheimer's disease, an early form of frontotemporal dementia (FTD), Lewy body disease (DCL), or bipolar disorder (TBP) (confirm with trial site for exact diagnosis requirements)

Who may not be able to join:

  • You are not able to give valid consent, or you do not wish to take part
  • You are currently under legal guardianship

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: JEROME BRUNELIN, PHD, Centre Hospitalier Le Vinatier - CRNL - INSERM

Phone: 00334 37 91 55 65

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hôpital le Vinatier
Registry
ClinicalTrials.gov
Start date
8 March 2019
Est. completion
8 March 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

measure source memory performance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov